The National Institute of Health’s HEAL Partnership Committee provides a forum for sharing existing data and knowledge about past pain therapy development.
Avrio Health is using its portfolio of well-known brands in infection resilience, digestive wellness and health supplements and its experienced team to drive novel advances and consumer demand.
Ahead of the Food and Drug Administration’s planned public hearing about cannabis, the Consumer Health Products Association is sharing its position on how it thinks the agency should view CBD.
Franzia is unveiling its new Chardonnay, Pinot Grigio/Colombard, Rosé and Crisp White offerings, in addition to launching the ‘Franz for Life’ campaign.
Leading Edge Pharms is a biotechnology company focused on the research, development and commercialization of novel cannabinoid therapies and innovative delivery platforms.